Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors

التفاصيل البيبلوغرافية
العنوان: Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors
المؤلفون: David Deperthes, Takao Kataoka, Jürgen Engel, Jacqueline Romero, Nils Holler, Pedro Romero, Pascal Schneider, Jean-Luc Bodmer, Jürg Tschopp
المصدر: Journal of Immunological Methods, vol. 237, no. 1-2, pp. 159-173
سنة النشر: 2000
مصطلحات موضوعية: Fas Ligand Protein, Recombinant Fusion Proteins, CD40 Ligand, Immunology, Receptors, Fc, Cartilage Oligomeric Matrix Protein, Ligands, Lymphocyte Activation, Jurkat cells, Receptors, Tumor Necrosis Factor, Immunoglobulin G, Fas ligand, Jurkat Cells, Mice, Tumor Cells, Cultured, Animals, Humans, Matrilin Proteins, Immunology and Allergy, Avidity, fas Receptor, CD40 Antigens, Receptor, Glycoproteins, Mice, Knockout, Cartilage oligomeric matrix protein, B-Lymphocytes, Extracellular Matrix Proteins, Membrane Glycoproteins, CD40, biology, Chemistry, Virology, In vitro, Cell biology, Solubility, biology.protein, Antigens, CD40/metabolism, Antigens, CD95/metabolism, B-Lymphocytes/cytology, B-Lymphocytes/drug effects, Extracellular Matrix Proteins/genetics, Extracellular Matrix Proteins/metabolism, Glycoproteins/genetics, Glycoproteins/metabolism, Lymphocyte Activation/drug effects, Membrane Glycoproteins/antagonists & inhibitors, Membrane Glycoproteins/metabolism, Receptors, Fc/genetics, Receptors, Fc/metabolism, Receptors, Tumor Necrosis Factor/genetics, Receptors, Tumor Necrosis Factor/metabolism, Recombinant Fusion Proteins/genetics, Recombinant Fusion Proteins/metabolism
الوصف: TNF receptor family members fused to the constant domain of immunoglobulin G have been widely used as immunoadhesins in basic in vitro and in vivo research and in some clinical applications. In this study, we assemble soluble, high avidity chimeric receptors on a pentameric scaffold derived from the coiled-coil domain of cartilage oligomeric matrix protein (COMP). The affinity of Fas and CD40 (but not TNFR-1 and TRAIL-R2) to their ligands is increased by fusion to COMP, when compared to the respective Fc chimeras. In functional assays, Fas:COMP was at least 20-fold more active than Fas:Fc at inhibiting the action of sFasL, and CD40:COMP could block CD40L-mediated proliferation of B cells, whereas CD40:Fc could not. In conclusion, members of the TNF receptor family can display high specificity and excellent avidity for their ligands if they are adequately multimerized.
وصف الملف: application/pdf
اللغة: English
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2d98abe1adc5f23e0e9aa537d56a090Test
https://serval.unil.ch/notice/serval:BIB_69A67AAF39A6Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....c2d98abe1adc5f23e0e9aa537d56a090
قاعدة البيانات: OpenAIRE